The broad markets in the U.S. opened lower Monday morning, not from a weakness in the earnings season or even a huge dip in commodities. In fact it was an issue with the Chinese markets. The (Shanghai) SSE Composite Index dropped nearly 8.5%, the single greatest daily loss in almost a decade. Separately the (Hong Kong) Hang Seng Index was down 3.1%.
24/7 Wall St has chosen a few Chinese stocks and funds to see how the market reacted: iShares China Large-Cap (NYSEMKT: FXI), Direxion Daily FTSE China Bull 3X EFT (NYSEMKT: YINN), Templeton Dragon Fund, Inc. (NYSE: TDF), and iShares MSCI China (NYSEMKT: MCHI).
On Monday morning, shares of FXI were down 4.1% at $40.05 within its 52-week trading range of $36.72 to $52.85. It’s worth noting that shares are down 24.2% from their 52-week high. So far on the year shares are up 0.8% year to date.
YINN was down 12% year to date, and nearly an additional 12% from Friday’s close to $27.63. It has a 52-week trading range of $24.96 to $68.54 with units valued 59.7% lower than the high.
Shares of the Templeton Dragon Fund were down 3% at $22.81 on a 52-week trading range of $21.93 to $28.25. From the 52-week high shares are down 19.3% and so far are down 2% year to date.
MCHI shares were down 4% at $49.46. The stock has a range of $45.59 to $64.58, and shares are down 23.4% from the high. Year to date shares were actually up 2.7% prior to this trading session.
NVIDIA has returned 250-fold in the past 10 years as artificial intelligence took off.
But if you missed out on NVIDIA’s historic run, your chance to see life-changing profits from AI isn’t over.
The 24/7 Wall Street Analyst who first called NVIDIA’s AI-fueled rise in 2009 just published a brand-new research report named “The Next NVIDIA.”
The report outlines key breakthroughs in AI and the stocks ready to dominate the next wave of growth. The report is absolutely free. Simply enter your email below
By providing your email address, you agree to receive communications from us regarding website updates and other offerings that may be of interest to you.
You have the option to opt-out of these emails at any moment. For more information, please review our Disclaimer and Terms of Use.